Whether antimicrobial resistance can be contained before it becomes a leading global cause of death, and whether new drug pipelines can keep pace.
Scope: Antimicrobial resistance, pharmaceutical R&D, public health policy, agricultural antibiotics
The antibiotics crisis, driven by antimicrobial resistance (AMR), presents a complex global health challenge. While the scientific community and public health organizations are increasingly aware of the threat, the pace of new antibiotic development struggles to keep up with the evolution of resistant pathogens. Different strategies are being deployed across public health policy, pharmaceutical R&D, and agriculture to mitigate the crisis, but their collective efficacy and global coordination remain uncertain.
Is the new 'miracle' weight-loss drug 'Slim-Gen' a revolutionary breakthrough or a dangerous, unregulated health risk?
80%Slim-Gen is sweeping Hollywood with 30kg-in-a-month results. Early adverse-event reports are alarming regulators.
Will the global 'loneliness epidemic' be officially recognized as a public health crisis by the WHO by 2027?
75%Studies link loneliness to dementia, heart disease and shorter lifespans. Several governments already appointed loneliness ministers.
Will longevity drugs extend average human lifespan past 100 by 2050?
15%Tracking the development of anti-aging therapeutics from senolytics to rapamycin analogs. Monitoring clinical trial results, biomarker validation, and the transition from longevity research to approved therapies.
Is the longevity industry about to break through?
65%Whether anti-aging science — senolytics, epigenetic reprogramming, rapamycin — will deliver meaningful life extension within a decade.
Will the widespread implementation of AI in medical diagnostics lead to a significant reduction in misdiagnosis rates by 2028?
65%The integration of AI into medical diagnostics is a rapidly developing field, with many promising trials and increasing adoption. There's a strong online discussion about whether this will translate into tangible improvements in patient care, specifically by reducing the incidence of misdiagnosis, which remains a significant problem globally.
Will the infamous 'gene-editing for vanity' clinic in Dubai be shut down by international pressure before 2027?
65%The clinic offers eye color, height and IQ "upgrades" for embryos. Bioethicists are furious; ultra-rich clients keep flying in.